Literature DB >> 33634932

Deep Learning Whole-Gland and Zonal Prostate Segmentation on a Public MRI Dataset.

Renato Cuocolo1,2, Albert Comelli3, Alessandro Stefano4, Viviana Benfante4, Navdeep Dahiya5, Arnaldo Stanzione6, Anna Castaldo6, Davide Raffaele De Lucia6, Anthony Yezzi5, Massimo Imbriaco6.   

Abstract

BACKGROUND: Prostate volume, as determined by magnetic resonance imaging (MRI), is a useful biomarker both for distinguishing between benign and malignant pathology and can be used either alone or combined with other parameters such as prostate-specific antigen.
PURPOSE: This study compared different deep learning methods for whole-gland and zonal prostate segmentation. STUDY TYPE: Retrospective. POPULATION: A total of 204 patients (train/test = 99/105) from the PROSTATEx public dataset. FIELD STRENGTH/SEQUENCE: A 3 T, TSE T2 -weighted. ASSESSMENT: Four operators performed manual segmentation of the whole-gland, central zone + anterior stroma + transition zone (TZ), and peripheral zone (PZ). U-net, efficient neural network (ENet), and efficient residual factorized ConvNet (ERFNet) were trained and tuned on the training data through 5-fold cross-validation to segment the whole gland and TZ separately, while PZ automated masks were obtained by the subtraction of the first two. STATISTICAL TESTS: Networks were evaluated on the test set using various accuracy metrics, including the Dice similarity coefficient (DSC). Model DSC was compared in both the training and test sets using the analysis of variance test (ANOVA) and post hoc tests. Parameter number, disk size, training, and inference times determined network computational complexity and were also used to assess the model performance differences. A P < 0.05 was selected to indicate the statistical significance.
RESULTS: The best DSC (P < 0.05) in the test set was achieved by ENet: 91% ± 4% for the whole gland, 87% ± 5% for the TZ, and 71% ± 8% for the PZ. U-net and ERFNet obtained, respectively, 88% ± 6% and 87% ± 6% for the whole gland, 86% ± 7% and 84% ± 7% for the TZ, and 70% ± 8% and 65 ± 8% for the PZ. Training and inference time were lowest for ENet. DATA
CONCLUSION: Deep learning networks can accurately segment the prostate using T2 -weighted images. EVIDENCE LEVEL: 4 TECHNICAL EFFICACY: Stage 2.
© 2021 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  deep learning; machine learning; magnetic resonance imaging; prostate; prostatic neoplasms

Year:  2021        PMID: 33634932     DOI: 10.1002/jmri.27585

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

1.  Automatic zonal segmentation of the prostate from 2D and 3D T2-weighted MRI and evaluation for clinical use.

Authors:  Dimitri Hamzaoui; Sarah Montagne; Raphaële Renard-Penna; Nicholas Ayache; Hervé Delingette
Journal:  J Med Imaging (Bellingham)       Date:  2022-03-14

2.  Development and validation of the 3D U-Net algorithm for segmentation of pelvic lymph nodes on diffusion-weighted images.

Authors:  Xiang Liu; Zhaonan Sun; Chao Han; Yingpu Cui; Jiahao Huang; Xiangpeng Wang; Xiaodong Zhang; Xiaoying Wang
Journal:  BMC Med Imaging       Date:  2021-11-13       Impact factor: 1.930

Review 3.  Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities.

Authors:  Huanye Li; Chau Hung Lee; David Chia; Zhiping Lin; Weimin Huang; Cher Heng Tan
Journal:  Diagnostics (Basel)       Date:  2022-01-24

4.  AutoProstate: Towards Automated Reporting of Prostate MRI for Prostate Cancer Assessment Using Deep Learning.

Authors:  Pritesh Mehta; Michela Antonelli; Saurabh Singh; Natalia Grondecka; Edward W Johnston; Hashim U Ahmed; Mark Emberton; Shonit Punwani; Sébastien Ourselin
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

5.  A New Preclinical Decision Support System Based on PET Radiomics: A Preliminary Study on the Evaluation of an Innovative 64Cu-Labeled Chelator in Mouse Models.

Authors:  Viviana Benfante; Alessandro Stefano; Albert Comelli; Paolo Giaccone; Francesco Paolo Cammarata; Selene Richiusa; Fabrizio Scopelliti; Marco Pometti; Milene Ficarra; Sebastiano Cosentino; Marcello Lunardon; Francesca Mastrotto; Alberto Andrighetto; Antonino Tuttolomondo; Rosalba Parenti; Massimo Ippolito; Giorgio Russo
Journal:  J Imaging       Date:  2022-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.